Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
The firm outlined the ways it continues to diversify its core business while expanding both its headcount and footprint.
Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development
The companies will cooperate in drug target discovery and, potentially, companion diagnostic development for novel synthetic lethal inhibitors.
Sorrento Therapeutics, National Institute of Genomic Medicine of Mexico to Form SARS-CoV-2 Alliance
The partners will work together on a range of products for the diagnosis and treatment of SARS-CoV-2, which will be commercialized in Mexico.
The digital pathology firm is working to further develop its diagnostic capabilities and broaden its menu of algorithms for different diseases.
Caris Life Sciences, Elevation Oncology Team on Targeted Drug Development
The companies are working together to mine Caris' multiomic data for new cancer drug targets, sharing drug/diagnostic development costs for chosen candidates.